The Global Semisolid Dosage Form Market was valued at USD 82.5 Billion in 2024 and is projected to reach USD 112.3 Billion by 2030, growing at a Compound Annual Growth Rate (CAGR) of 5.2% during the forecast period (2024–2030). This robust expansion is fueled by the rising prevalence of chronic skin conditions, increasing geriatric population, technological advancements in drug delivery systems, and the growing consumer preference for topical treatments over oral medications due to localized action and reduced systemic side effects.

As the pharmaceutical landscape evolves with a focus on patient-centric formulations and enhanced bioavailability, the companies leading the development and manufacturing of semisolid dosage forms are at the forefront of this transformation. In this blog, we profile the Top 10 Companies in the Semisolid Dosage Form Market—a mix of global pharmaceutical giants and specialized dermatology-focused innovators shaping the future of topical and localized drug delivery.

Download FREE Sample Report:
Semisolid Dosage Form Market – View in Detailed Research Report

---

🔟 1. Johnson & Johnson

Headquarters: New Brunswick, New Jersey, USA
Key Offering: Creams, Ointments, Gels, Dermatological Lotions

Johnson & Johnson, through its Janssen Pharmaceutical and Consumer Health divisions, is a dominant force in the semisolid dosage form market. The company offers a wide array of topical prescription and over-the-counter (OTC) products for dermatological, analgesic, and antifungal applications.

Innovation & Market Strategy:

• Focus on innovative drug delivery technologies for psoriasis, eczema, and acne

• Extensive R&D in nanotechnology for enhanced skin penetration

• Strong global supply chain and manufacturing footprint

---

9️⃣ 2. GlaxoSmithKline plc (GSK)

Headquarters: Brentford, London, UK
Key Offering: Topical Corticosteroids, Analgesic Creams, Medicated Ointments

GSK is a leading global healthcare company with a significant portfolio of semisolid formulations. Their dermatology and consumer healthcare segments produce some of the world’s most recognized topical brands, targeting inflammatory skin diseases and pain management.

Innovation & Market Strategy:

• Investment in novel formulation science for improved patient adherence

• Strategic focus on OTC dermatology growth markets

---

8️⃣ 3. Bayer AG

Headquarters: Leverkusen, Germany
Key Offering: Antifungal Creams, Dermatological Preparations, Wound Care Ointments

Bayer’s consumer health division is a key player in the semisolid market, offering a range of topical solutions. The company leverages its strong R&D capabilities to develop advanced formulations for self-care and prescription dermatology.

Innovation & Market Strategy:

• Development of combination therapies in semisolid formulations

• Expansion in emerging markets with tailored product portfolios

---

7️⃣ 4. Novartis AG

Headquarters: Basel, Switzerland
Key Offering: Prescription Dermatological Gels, Creams, Ointments for Psoriasis and Eczema

Novartis, through its Sandoz division and innovative medicines portfolio, is a major contributor to the semisolid dosage form landscape. The company focuses on high-value, complex generic and novel topical formulations for chronic skin conditions.

Innovation & Market Strategy:

• Leadership in biosimilar and complex generic topical products

• R&D in targeted delivery systems for improved efficacy

Download FREE Sample Report:
Semisolid Dosage Form Market – View in Detailed Research Report

---

6️⃣ 5. Sun Pharmaceutical Industries Ltd.

Headquarters: Mumbai, India
Key Offering: Generic and Specialty Topicals, Dermatological Creams, Gels

Sun Pharma is one of the world’s largest specialty generic pharmaceutical companies and a significant manufacturer of semisolid dosage forms. The company has a robust portfolio of dermatology products and a strong global presence, particularly in the US market.

Innovation & Market Strategy:

• Strong pipeline of complex generic topical products

• Strategic acquisitions to strengthen dermatology footprint

---

5️⃣ 6. LEO Pharma

Headquarters: Ballerup, Denmark
Key Offering: Specialty Dermatological Creams, Ointments, Gels for Psoriasis, Eczema, Acne

LEO Pharma is a global leader dedicated solely to dermatology. The company’s entire focus is on developing and marketing innovative treatments for skin diseases, making it a pure-play powerhouse in the semisolid dosage form market.

Innovation & Market Strategy:

• Dedicated R&D in dermatological drug delivery

• Patient-centric formulation development

---

4️⃣ 7. Perrigo Company plc

Headquarters: Dublin, Ireland
Key Offering: OTC Topical Analgesics, Acne Treatments, Antifungals, Skin Protectants

Perrigo is a leading provider of quality, affordable self-care products and a major manufacturer of store-brand OTC semisolid formulations. The company supplies a vast portfolio of topical products to retailers worldwide.

Innovation & Market Strategy:

• Extensive portfolio of OTC topical monograph products

• Leadership in store-brand dermatologicals

---

3️⃣ 8. Bausch Health Companies Inc.

Headquarters: Laval, Quebec, Canada
Key Offering: Prescription Dermatologicals, Acne Therapies, Topical Retinoids

Bausch Health, through its Ortho Dermatologics division, is a prominent player in the medical dermatology space. The company markets a range of branded prescription semisolid products for various skin conditions.

Innovation & Market Strategy:

• Focus on branded dermatological products with clinical differentiation

• Strategic licensing and acquisition of novel topical therapies

---

2️⃣ 9. Glenmark Pharmaceuticals Ltd.

Headquarters: Mumbai, India
Key Offering: Generic Dermatological Creams, Ointments, Topical Steroids

Glenmark is a global research-led pharmaceutical company with a strong presence in the dermatology segment. The company has a diversified portfolio of semisolid dosage forms and a robust pipeline of complex generic topical products.

Innovation & Market Strategy:

• Development of difficult-to-formulate generic topicals

• Focus on regulated markets like the US and Europe

---

1️⃣ 10. Cipla Ltd.

Headquarters: Mumbai, India
Key Offering: Affordable Dermatological Formulations, Antifungals, Topical Antibiotics

Cipla is a global pharmaceutical company known for its extensive portfolio of affordable medicines. The company has a significant presence in the semisolid dosage form market, with a wide range of topical products catering to both developed and emerging economies.

Innovation & Market Strategy:

• Focus on accessibility and affordability of dermatological treatments

• Expansion of respiratory and topical product portfolio in key markets

Get Full Report Here:
Semisolid Dosage Form Market – View in Detailed Research Report

---

🌍 Outlook: The Future of Semisolid Dosage Forms is Smarter and More Targeted

The semisolid dosage form market is undergoing a significant evolution. While traditional creams and ointments continue to dominate, the industry is innovating with advanced drug delivery systems, personalized medicine approaches, and sustainable packaging solutions.

📈 Key Trends Shaping the Market:

• Rapid adoption of nanotechnology for enhanced skin penetration and targeted delivery

• Growing demand for combination therapies in single formulations

• Increasing focus on biologics and biosimilars in topical formulations

• Rise of cosmeceuticals and OTC dermatologicals

Get Full Report Here:
Semisolid Dosage Form Market – View in Detailed Research Report

The companies listed above are not only supplying essential topical treatments—they’re pioneering the next generation of dermatological and localized drug delivery solutions that improve patient outcomes and quality of life.